Director's Dealing • Aug 4, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
News Details
Directors’ Dealings | 4 August 2023 13:36
Fresenius SE & Co. KGaA: Dr. Michael Moser, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
04.08.2023 / 13:35 CET/CEST
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
| Title: | Dr. |
| First name: | Michael |
| Last name(s): | Moser |
2. Reason for the notification
a) Position / status
| Position: | Member of the managing body |
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Fresenius SE & Co. KGaA
b) LEI
XDFJ0CYCOO1FXRFTQS51
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
| Type: | Share |
| ISIN: | DE0005785604 |
b) Nature of the transaction
| Acquisition |
| Transaction linked to the exercise of share option programmes |
c) Price(s) and volume(s)
| Price(s) | Volume(s) |
| 28.34 EUR | 40,724.58 EUR |
| 28.35 EUR | 70,931.70 EUR |
| 28.36 EUR | 30,798.96 EUR |
| 28.37 EUR | 32,738.98 EUR |
| 28.38 EUR | 75,348.90 EUR |
| 28.32 EUR | 22,429.44 EUR |
| 28.33 EUR | 27,593.42 EUR |
d) Aggregated information
| Price | Aggregated volume |
| 28.3553 EUR | 300,565.9800 EUR |
e) Date of the transaction
2023-08-03; UTC+2
f) Place of the transaction
| Name: | XETRA |
| MIC: | XETR |
04.08.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Fresenius SE & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg v.d.H. | |
| Germany | |
| Internet: | www.fresenius.com |
| End of News | EQS News Service |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.